Wearable device zaps pancreatic tumors alongside chemo in new trial

NCT ID NCT07284277

Recruiting now Disease control Sponsor: Clinica Universidad de Navarra, Universidad de Navarra Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a wearable medical device that delivers low-intensity electric fields (called TTFields) is safe and effective when used alongside a standard chemotherapy regimen for metastatic pancreatic cancer. The trial will enroll about 30 adults to see if the combination can better control the cancer and improve survival. Researchers will closely monitor side effects, how well patients tolerate the device, and whether the treatment slows cancer growth.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Clínica Universidad de Navarra
RECRUITING

Pamplona, Navarre, 31008, Spain
Fundación Jiménez-Díaz
NOT_YET_RECRUITING

Madrid, 28040, Spain
Hospital Universitario de Araba
NOT_YET_RECRUITING

Vitoria-Gasteiz, Álava, 01009, Spain
Hospital Universitario de Cruces
NOT_YET_RECRUITING

Barakaldo, Vizcaya, 48903, Spain
Hospital de Galdakao
NOT_YET_RECRUITING

Galdakao, Vizcaya, 48960, Spain

Conditions

Explore the condition pages connected to this study.

PANCREATIC ADENOCARCINOMA METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA